Showing results (691-700 of 3,032) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|March 21, 2025
Network pharmacology of ginsenoside Rg3 in the treatment of ovarian cancer: Mechanism of action and experimental verificationYibo Zhu, Xizi Lu, Xiaofeng Ding, et al.International Journal of Clinical Pharmacology and Therapeutics|October 9, 2024
A disproportionality analysis of antipsychotic-induced hyperprolactinemia based on FDA adverse event reporting systemMin Song, Dong Li, Jing Peng, et al.International Journal of Clinical Pharmacology and Therapeutics|August 9, 2024
Pulmonary fibrosis insights and therapy targets from disease models and administration of the lipophilic diterpene, sodium tanshinone IIA sulfonate: Review and meta-analysisLi-Ying Peng, Jun-Jun Shi, Yue Liang, et al.International Journal of Clinical Pharmacology and Therapeutics|July 30, 2024
Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional studyArtur Bauhofer, Ümniye Balaban, Sonja Schimo, et al.International Journal of Clinical Pharmacology and Therapeutics|July 22, 2024
A case study of impaired consciousness caused by alcohol consumption in a pediatric patient taking high-dose cefiximeLi Zheng, Gen Li, Liaoyun ZhangInternational Journal of Clinical Pharmacology and Therapeutics|June 26, 2024
Favipiravir pharmacokinetics in COVID-19 patients with moderate to severe kidney dysfunction: Lessons learnedNursel Sürmelioğlu, Esra Demirtürk, Nazire Ateş Ayhan, et al.International Journal of Clinical Pharmacology and Therapeutics|June 26, 2024
Membrane P-glycoprotein expression in lymphocytes from adult patients with refractory glomerulonephritisShanshan Jin, Xinrong Zou, Xue Xue, et al.International Journal of Clinical Pharmacology and Therapeutics|June 25, 2024
Network pharmacology analysis and molecular docking using the Chinese herbal agent WYHX formula (according to Yan Dexin): Management of coronary artery diseaseZi-Yang Wang, Miao Zhou, Yong-Ning Sun, et al.International Journal of Clinical Pharmacology and Therapeutics|May 3, 2024
Pegylated-interferon alpha (PEG-IFNα)-induced interstitial lung disease in a patient with chronic hepatitis B: A case report and literature reviewMinghui Shi, Shiyao Wang, Yanhong Ren, et al.International Journal of Clinical Pharmacology and Therapeutics|May 3, 2024
Degree of serum LDL cholesterol reduction by simvastatin and ezetimibe is dependent on baseline LDL cholesterol concentration but not on baseline values and changes in cholesterol synthesis and absorption parametersDieter Lütjohann, Frans StellaardPageof 304